Healthcare Industry News: PhotonMD
News Release - July 6, 2017
PhotonMD Appoints Robert Catlin as Senior Director of MarketingMedical Device Business Adds Accomplished Executive
MORRISVILLE, N.C., July 6, 2017 -- (Healthcare Sales & Marketing Network) -- PhotonMD™, Inc. an innovator in photomedicine devices, announced today that Robert Catlin IV has joined the Company as Senior Director of Marketing to further develop their growing photomedicine device business and lead the commercial efforts. Rob is an award-winning marketing and sales leader in the medical device and pharmaceutical industries. Joining in advance of the launch of PhotonMD's new direct to consumer aesthetic product, Rob will continue his impact on the health and well-being of people's lives.
Rob brings with him nearly 2 decades of experience developing and executing strategic business plans for market leading medical devices. He will be responsible for PhotonMD's physician and consumer relationship building and rapidly increasing market penetration and brand awareness in the consumer aesthetic marketplace.
"Rob's medical device and market experience uniquely positions him to lead the commercial strategy of PhotonMD as we continue to develop and drive to our goal of transforming lives through photomedicine. With a proven track record for successfully leading large scale initiatives and driving innovation, Rob's leadership skills and experience executing strategic visions are well suited to lead PhotonMD's commercial efforts that will drive us to be a leader in our industry," said Dr. Nick Medendorp, Jr., President and CEO of PhotonMD.
Most recently, Rob was Sr. Director of Marketing for Merz Aesthetics Devices. There, he enhanced new product development, created all consumer and physician marketing campaigns for the Cellfina® System, and delivered category leadership within six months of launch. Rob contributed to overall revenue growth and won five awards for his efforts, including Allure's 2015, "Best of Beauty Breakthrough".
"I am thrilled to join the PhotonMD team. I believe the potential for growth and value creation is tremendous, given the talented and passionate people at PhotonMD. Having played leadership roles in similar business situations and industries, I am confident that we can execute the commercial plans to drive consistent sales and margin growth. I look forward to becoming part of the PhotonMD family and partnering with the team to build the business," said Catlin.
In addition to his prior business development and sales growth experience, Rob has extensive experience with successfully executing consumer, professional and new product launches to drive revenue and increase market share. Before working for Merz, Rob was the director of marketing for Medicis Pharmaceutical's Restylane® family of products. Prior to that, he managed the southeast sales team for Medicis and was a brand manager for Allergan Medical. One of Rob's key accomplishments in the industry was developing and implementing the Allergan Partner Privileges Program, a hallmark physician loyalty program currently used by Allergan. In 2016, Rob was counted among Aesthetic Everything's Top 10 Company Executives.
Catlin holds a B.S. in Finance and Marketing from Florida State University and an M.B.A from the University of Southern California.
PhotonMD 's Modulated Light Therapy™ technology is based on a photomedicine platform that can be delivered in a variety of doses and tailored form factors for specific indications. For more information, please visit www.PhotonMD.com.
Except for historical information, all the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: reliance on key personnel; the early stage of our business; risks associated with the medical device and drug development processes; competition; and other risks described in other Company press releases and presentations. PhotonMD assumes no obligation and do not intend to update these forward-looking statements, except as required by law.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.